• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MARK4 的泛素结合域在生理 pH 值下提供稳定性。

Ubiquitin-associated domain of MARK4 provides stability at physiological pH.

机构信息

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.

Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi 110025, India.

出版信息

Int J Biol Macromol. 2016 Dec;93(Pt A):1147-1154. doi: 10.1016/j.ijbiomac.2016.09.087. Epub 2016 Sep 24.

DOI:10.1016/j.ijbiomac.2016.09.087
PMID:27677563
Abstract

Microtubule affinity regulating Kinase 4 (MARK4) belongs to the family of AMP-activated protein kinase. It phosphorylates microtubule associated proteins at specific sites (Serine in KXGS motifs) in the microtubule-binding repeats. In our previous studies, two constructs, namely, kinase domain with 59 N-terminal residues (residues 1-310) and only kinase domain (residues 59-310) of MARK4 show aggregation at physiological pH. However, these two constructs were stable at extremes of pH conditions. Now the question arises: how is MARK4 stable at physiological pH in-vivo? To answer this question, we have successfully cloned, expressed, and purified UBA-domain along with the kinase domain of MARK4 and performed spectroscopic measurements and activity assays. We observed a pronounced secondary and tertiary structure and ATPase activity in the MARK4 at physiological pH. In conclusion, UBA domain may be important to maintain the structure, stability and activity of MARK4 under physiological conditions.

摘要

微管亲和调节激酶 4(MARK4)属于 AMP 激活蛋白激酶家族。它在微管结合重复序列中的特定位点(KXGS 模体中的丝氨酸)磷酸化微管相关蛋白。在我们之前的研究中,两种构建体,即具有 59 个 N 端残基(残基 1-310)的激酶结构域和仅激酶结构域(残基 59-310)的 MARK4,在生理 pH 下显示聚集。然而,这两种构建体在 pH 极端条件下是稳定的。现在的问题是:MARK4 在体内生理 pH 下是如何稳定的?为了回答这个问题,我们成功地克隆、表达和纯化了 MARK4 的 UBA 结构域和激酶结构域,并进行了光谱测量和活性测定。我们在生理 pH 下观察到 MARK4 具有明显的二级和三级结构和 ATP 酶活性。总之,UBA 结构域可能对 MARK4 在生理条件下的结构、稳定性和活性很重要。

相似文献

1
Ubiquitin-associated domain of MARK4 provides stability at physiological pH.MARK4 的泛素结合域在生理 pH 值下提供稳定性。
Int J Biol Macromol. 2016 Dec;93(Pt A):1147-1154. doi: 10.1016/j.ijbiomac.2016.09.087. Epub 2016 Sep 24.
2
Human microtubule affinity-regulating kinase 4 is stable at extremes of pH.人微管亲和力调节激酶4在极端pH值下稳定。
J Biomol Struct Dyn. 2016 Jun;34(6):1241-51. doi: 10.1080/07391102.2015.1074942. Epub 2015 Aug 21.
3
Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays.人微管亲和调节激酶 4 抑制剂的评价:荧光结合研究、酶和细胞测定。
J Biomol Struct Dyn. 2017 Nov;35(14):3194-3203. doi: 10.1080/07391102.2016.1249958. Epub 2016 Nov 3.
4
Microtubule affinity-regulating kinase 4: structure, function, and regulation.微管亲和调节激酶 4:结构、功能和调节。
Cell Biochem Biophys. 2013 Nov;67(2):485-99. doi: 10.1007/s12013-013-9550-7.
5
Atypical PKC phosphorylates microtubule affinity-regulating kinase 4 in vitro.非典型蛋白激酶C在体外使微管亲和力调节激酶4磷酸化。
Mol Cell Biochem. 2015 Dec;410(1-2):223-8. doi: 10.1007/s11010-015-2555-3. Epub 2015 Sep 7.
6
PKR-inhibitor binds efficiently with human microtubule affinity-regulating kinase 4.PKR抑制剂与人微管亲和力调节激酶4有效结合。
J Mol Graph Model. 2015 Nov;62:245-252. doi: 10.1016/j.jmgm.2015.10.009. Epub 2015 Oct 21.
7
Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression.研究柠檬醛与 MARK4 之间识别的分子机制:一种减弱癌细胞进展的新治疗方法。
Int J Biol Macromol. 2018 Feb;107(Pt B):2580-2589. doi: 10.1016/j.ijbiomac.2017.10.143. Epub 2017 Oct 24.
8
Designing New Kinase Inhibitor Derivatives as Therapeutics Against Common Complex Diseases: Structural Basis of Microtubule Affinity-Regulating Kinase 4 (MARK4) Inhibition.设计新型激酶抑制剂衍生物作为常见复杂疾病的治疗药物:微管亲和力调节激酶4(MARK4)抑制的结构基础
OMICS. 2015 Nov;19(11):700-11. doi: 10.1089/omi.2015.0111.
9
MARK4 is a novel microtubule-associated proteins/microtubule affinity-regulating kinase that binds to the cellular microtubule network and to centrosomes.MARK4是一种新型的微管相关蛋白/微管亲和力调节激酶,它可与细胞微管网络及中心体相结合。
J Biol Chem. 2004 Feb 13;279(7):5915-23. doi: 10.1074/jbc.M304528200. Epub 2003 Nov 1.
10
Estimation of pH effect on the structure and stability of kinase domain of human integrin-linked kinase.估计 pH 值对人整合素连接激酶激酶结构域的结构和稳定性的影响。
J Biomol Struct Dyn. 2019 Jan;37(1):156-165. doi: 10.1080/07391102.2017.1420492. Epub 2018 Jan 7.

引用本文的文献

1
Tauopathy in AD: Therapeutic Potential of MARK-4.阿尔茨海默病中的tau蛋白病:MARK-4的治疗潜力。
Curr Alzheimer Res. 2024;21(11):779-790. doi: 10.2174/0115672050358397250126151707.
2
Apigenin-mediated MARK4 inhibition: a novel approach in advancing Alzheimer's disease therapeutics.芹菜素介导的MARK4抑制作用:推进阿尔茨海默病治疗的新方法。
Mol Divers. 2025 Jan 22. doi: 10.1007/s11030-025-11104-x.
3
Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.香草醛-异吲哚酮杂合物诱导的MARK4抑制作为一种有前景的肝细胞癌治疗策略
ACS Omega. 2024 Jun 5;9(24):25945-25959. doi: 10.1021/acsomega.4c00661. eCollection 2024 Jun 18.
4
Design, synthesis, molecular docking and anti-proliferative activity of novel phenothiazine containing imidazo[1,2-]pyridine derivatives against MARK4 protein.新型含吩噻嗪咪唑并[1,2 -]吡啶衍生物对MARK4蛋白的设计、合成、分子对接及抗增殖活性
RSC Med Chem. 2024 Apr 19;15(6):1942-1958. doi: 10.1039/d4md00059e. eCollection 2024 Jun 19.
5
Rv2231c, a unique histidinol phosphate aminotransferase from Mycobacterium tuberculosis, supports virulence by inhibiting host-directed defense.结核分枝杆菌中独特的组氨酸磷酸氨基转移酶 Rv2231c 通过抑制宿主定向防御来支持毒力。
Cell Mol Life Sci. 2024 May 2;81(1):203. doi: 10.1007/s00018-024-05200-8.
6
Interaction of Sp1 and Setd8 promotes vascular smooth muscle cells apoptosis by activating Mark4 in vascular calcification.Sp1 和 Setd8 通过激活 Mark4 促进血管平滑肌细胞凋亡在血管钙化中。
Aging (Albany NY). 2024 Feb 1;16(3):2438-2456. doi: 10.18632/aging.205492.
7
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma.一种基于网络引导的方法来发现基于植物化学物质的抗癌疗法:针对肝细胞癌的MARK4靶点
Front Oncol. 2022 Jul 22;12:914032. doi: 10.3389/fonc.2022.914032. eCollection 2022.
8
Discovery of 4-(2-(dimethylamino)ethoxy)benzohydrazide derivatives as prospective microtubule affinity regulating kinase 4 inhibitors.4-(2-(二甲基氨基)乙氧基)苯甲酰肼衍生物作为潜在微管亲和调节激酶4抑制剂的发现
RSC Adv. 2020 May 27;10(34):20129-20137. doi: 10.1039/d0ra00453g. eCollection 2020 May 26.
9
MAP/Microtubule Affinity Regulating Kinase 4 Inhibitory Potential of Irisin: A New Therapeutic Strategy to Combat Cancer and Alzheimer's Disease.鸢尾素抑制丝氨酸/苏氨酸蛋白激酶 MAP/Microtubule Affinity Regulating Kinase 4 的潜力:一种对抗癌症和阿尔茨海默病的新治疗策略。
Int J Mol Sci. 2021 Oct 12;22(20):10986. doi: 10.3390/ijms222010986.
10
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.MARK4 受 AChE 抑制剂(多奈哌齐和重酒石酸卡巴拉汀)抑制:对阿尔茨海默病治疗的新见解。
Biomolecules. 2020 May 20;10(5):789. doi: 10.3390/biom10050789.